We are live on
!
Find out more
O
OppenheimerFunds Portfolio holdings
AUM
$80.4B
1-Year Est. Return
15.1%
This Fund
S&P 500
This Quarter
Est. Return
+2%
1 Year Est. Return
+15.1%
3 Year Est. Return
+72.05%
5 Year Est. Return
+91.1%
10 Year Est. Return
–
AUM
$89.6B
AUM Growth
-$307M
(-0.34%)
Cap. Flow
-$521M
Cap. Flow
% of AUM
-0.58%
Top 10 Holdings %
Top 10 Hldgs %
13.13%
Holding
1,015
New
93
Increased
423
Reduced
329
Closed
118
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$536M |
| 2 |
WPZ
Williams Partners L.P.
WPZ
|
+$409M |
| 3 |
PepsiCo
PEP
|
+$325M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$220M |
| 5 |
PG&E
PCG
|
+$218M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Petrobras Class A
PBR.A
|
+$417M |
| 2 |
WPZ
WILLIAMS PARTNERS L.P. COM UTS REPTG L.P. INT
WPZ
|
+$383M |
| 3 |
AGN
Allergan Inc
AGN
|
+$340M |
| 4 |
AbbVie
ABBV
|
+$257M |
| 5 |
Exelon
EXC
|
+$250M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 17.02% |
| 2 | Financials | 13.78% |
| 3 | Healthcare | 12.41% |
| 4 | Communication Services | 11.87% |
| 5 | Consumer Discretionary | 10.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Illumina
ILMN
$29.4B
| $137M | 0.15% |
759,438
-44,032
| -5% | -$8.29M |
|
177
CSX Corp
CSX
$98.6B
| $137M | 0.15% |
12,383,826
+3,283,260
| +36% | +$37.8M |
|
178
Edison International
EIX
$30.7B
| $137M | 0.15% |
2,185,047
+53,772
| +3% | +$3.51M |
|
179
Thermo Fisher Scientific
TMO
$211B
| $136M | 0.15% |
1,012,081
+2,943
| +0.3% | +$379K |
|
180
Dollar Tree
DLTR
$23.1B
| $135M | 0.15% |
1,657,680
+1,407,590
| +563% | +$107M |
|
181
Brinker International
EAT
$8.02B
| $133M | 0.15% |
2,164,851
+765,349
| +55% | +$46.1M |
|
|
OCR
182
DELISTED
OMNICARE INC
OCR
| $133M | 0.15% |
1,727,615
+31,270
| +2% | +$2.38M |
|
183
Navient
NAVI
$774M
| $131M | 0.15% |
6,446,786
+3,879,519
| +151% | +$79.7M |
|
184
Guidewire Software
GWRE
$11.5B
| $131M | 0.15% |
2,482,207
-417,364
| -14% | -$21.6M |
|
185
NOV
NOV
$7.45B
| $129M | 0.14% |
2,577,745
-4,603,377
| -64% | -$250M |
|
186
Canadian Pacific Kansas City
CP
$82B
| $128M | 0.14% |
3,515,500
+152,500
| +5% | +$5.63M |
|
187
Ameriprise Financial
AMP
$46.8B
| $127M | 0.14% |
970,260
+92,070
| +10% | +$12.1M |
|
188
Cardinal Health
CAH
$53.4B
| $126M | 0.14% |
1,390,588
-474,501
| -25% | -$40.9M |
|
189
Amgen
AMGN
$203B
| $125M | 0.14% |
779,822
-26,262
| -3% | -$4.14M |
|
190
ResMed
RMD
$28.3B
| $124M | 0.14% |
1,726,530
+1,460,670
| +549% | +$94.9M |
|
|
STJ
191
DELISTED
St Jude Medical
STJ
| $121M | 0.14% |
1,855,000
+3,770
| +0.2% | +$251K |
|
192
Acadia Pharmaceuticals
ACAD
$4.25B
| $121M | 0.14% |
+3,709,507
| New | +$128M |
|
193
Sunoco
SUN
$14.2B
| $120M | 0.13% |
2,346,013
+216,210
| +10% | +$10.9M |
|
194
Itaú Unibanco
ITUB
$91.3B
| $120M | 0.13% |
27,114,288
-3,993,571
| -13% | -$19.5M |
|
195
Dana Inc
DAN
$2.91B
| $120M | 0.13% |
5,648,641
+225,484
| +4% | +$4.87M |
|
196
Universal Health Services
UHS
$9.43B
| $118M | 0.13% |
1,005,024
+33,020
| +3% | +$3.65M |
|
197
Digital Realty Trust
DLR
$73.7B
| $115M | 0.13% |
1,744,647
+385,298
| +28% | +$26.4M |
|
198
Global Partners
GLP
$1.64B
| $113M | 0.13% |
3,256,653
+7,140
| +0.2% | +$266K |
|
|
CLVS
199
DELISTED
Clovis Oncology, Inc.
CLVS
| $111M | 0.12% |
1,497,250
-279,724
| -16% | -$19.8M |
|
|
CPHD
200
DELISTED
Cepheid Inc
CPHD
| $111M | 0.12% |
1,948,480
+23,890
| +1% | +$1.34M |
|
Similar funds
TA
TCIM
HFS
SBAM
BB
SA
WF
BCPEM
OppenheimerFunds's Q1 2015 Portfolio in Review
As of Q1 2015, OppenheimerFunds held 1,015 positions worth $89.6B, down 0.34% from $89.9B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
OppenheimerFunds's Q1 2015 filing shows 93 new, 423 increased, 329 reduced and 118 closed positions. Its largest new stake was UBS Group: 30,806,912 shares worth $578M. The largest sale was Petrobras Class A, an estimated $417M.
By sector, the portfolio is most concentrated in Energy at 17% of assets, down from 19% a quarter earlier, followed by Financials and Healthcare.
- OppenheimerFunds's largest Q1 2015 buy was UBS Group: 30,806,912 shares worth $578M.
- OppenheimerFunds added most to Williams Partners L.P. in Q1 2015, an estimated $409M increase.
- OppenheimerFunds's biggest Q1 2015 reduction was AbbVie, cutting an estimated $257M.
- OppenheimerFunds fully exited Petrobras Class A in Q1 2015, selling an estimated $417M.
- OppenheimerFunds's ten largest holdings make up 13% of its $89.6B portfolio in Q1 2015.
- OppenheimerFunds opened 93 new positions and closed 118 in Q1 2015.
- OppenheimerFunds's portfolio value fell 0.34% quarter-over-quarter to $89.6B.
Based on OppenheimerFunds's 13F filing for Q1 2015, filed 15 May 2015.